Open | $31.930 |
Close | $30.940 |
Volume / Avg. | 2.380M / 1.505M |
Day Range | 30.860 - 32.175 |
52 Wk Range | 15.440 - 35.600 |
Market Cap | $5.096B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 10.69% |
Days to Cover | 13.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Revolution Medicines (NASDAQ: RVMD) through any online brokerage.
Other companies in Revolution Medicines’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Exact Sciences (NASDAQ:EXAS), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Revolution Medicines (NASDAQ: RVMD) was reported by Piper Sandler on Monday, March 11, 2024. The analyst firm set a price target for 43.00 expecting RVMD to rise to within 12 months (a possible 38.98% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Revolution Medicines (NASDAQ: RVMD) is $30.94 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Revolution Medicines.
Revolution Medicines’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Revolution Medicines.
Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.